Cinctive Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,863
Closed -$33.1K 478
2026
Q1
$33.1K Sell
16,863
-230,071
-93% -$540K ﹤0.01% 351
2025
Q4
$669K Sell
246,934
-5,003
-2% -$16.4K 0.04% 311
2025
Q3
$1.07M Buy
251,937
+161,937
+180% +$712K 0.05% 299
2025
Q2
$448K Buy
+90,000
New +$391K 0.02% 318
2021
Q1
Sell
-33,307
Closed -$1.34M 437
2020
Q4
$1.34M Sell
33,307
-59,327
-64% -$2.73M 0.11% 251
2020
Q3
$5.15M Buy
+92,634
New +$4.9M 0.45% 76

Other funds holding GDRX

Cinctive Capital Management's GDRX Position: Q2 2026 in Review

Cinctive Capital Management sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 16,863 shares — an estimated $33.1K sold.

Cinctive Capital Management first reported a position in GDRX in Q3 2020 and held it in 6 quarters. The position peaked at $5.15M in Q3 2020. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Cinctive Capital Management reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 16,863 GoodRx Holdings shares in Q2 2026, an estimated $33.1K.
  • Cinctive Capital Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 6 quarters.
  • Cinctive Capital Management's GoodRx Holdings position peaked at $5.15M in Q3 2020.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.